Upgrade to SI Premium - Free Trial

XBiotech (XBIT)

2.31 -0.06 (2.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/27/26 *Est.)

Latest Headlines

XBiotech starts phase II trial of vilamakitug for axial spondyloarthritis June 15, 2026 9:01 AM - StreetInsider XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis June 15, 2026 9:00 AM - StreetInsider Form 10-Q XBiotech Inc. For: Mar 31 May 14, 2026 2:44 PM - SEC Filing Form 10-K/A XBiotech Inc. For: Dec 31 April 29, 2026 1:02 PM - SEC Filing Full Article List